Amgen Inc.
AMGN
$312.47
-$2.25-0.72%
Headlines
5/19/2024
-
Ticker Report
5/19/2024
-
Ticker Report
5/19/2024
-
Ticker Report
5/19/2024
-
Fool.com Headlines
5/18/2024
-
Ticker Report
5/18/2024
-
Ticker Report
5/18/2024
-
Ticker Report
5/18/2024
-
Ticker Report
5/18/2024
-
Tickeron - Technical Analysis
5/17/2024
-
Ticker Report
5/17/2024
-
InvestorPlace
5/17/2024
-
Zacks Investment Research
5/17/2024
-
FiercePharma
5/17/2024
-
Market News Video
5/17/2024
-
Zacks Investment Research
5/17/2024
-
Benzinga
5/17/2024
-
TipRanks Financial Blog
5/16/2024
-
TipRanks Financial Blog
5/16/2024
-
The Fly
5/16/2024
-
PR Newswire
5/16/2024
-
New York Times - Business
5/16/2024
-
CNBC: Healthcare
5/16/2024
-
Seeking Alpha - Healthcare
5/16/2024
-
The Fly
5/16/2024
-
Market News Video
Filings
Friday, May 3, 2024
Sunday, March 31, 2024
Beginning of August (est)
Price History
Corporate Info
805 447 1000
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Thousand Oaks, CA 91320-1799
Business Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and...
more